Ossiam’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.12M | Buy |
7,337
+502
| +7% | +$322K | 0.07% | 120 |
|
|
2025
Q4 | $4.62M | Sell |
6,835
-4,159
| -38% | -$2.83M | 0.09% | 106 |
|
|
2025
Q3 | $7.02M | Buy |
10,994
+4,350
| +65% | +$2.64M | 0.09% | 163 |
|
|
2025
Q2 | $3.56M | Buy |
6,644
+1,731
| +35% | +$828K | 0.04% | 201 |
|
|
2025
Q1 | $2.06M | Sell |
4,913
-115
| -2% | -$49.9K | 0.03% | 225 |
|
|
2024
Q4 | $2.08M | Buy |
5,028
+1,105
| +28% | +$485K | 0.04% | 237 |
|
|
2024
Q3 | $1.98M | Buy |
3,923
+1,090
| +38% | +$530K | 0.04% | 217 |
|
|
2024
Q2 | $1.38M | Buy |
2,833
+92
| +3% | +$46.2K | 0.03% | 294 |
|
|
2024
Q1 | $1.48M | Sell |
2,741
-1,012
| -27% | -$553K | 0.03% | 299 |
|
|
2023
Q4 | $2.08M | Buy |
3,753
+557
| +17% | +$261K | 0.03% | 223 |
|
|
2023
Q3 | $1.4M | Buy |
3,196
+1,684
| +111% | +$840K | 0.02% | 283 |
|
|
2023
Q2 | $759K | Buy |
1,512
+629
| +71% | +$301K | 0.01% | 356 |
|
|
2023
Q1 | $442K | Buy |
883
+13
| +1% | +$6.22K | 0.01% | 401 |
|
|
2022
Q4 | $355K | Buy |
870
+74
| +9% | +$28.7K | 0.01% | 402 |
|
|
2022
Q3 | $259K | Buy |
796
+761
| +2,174% | +$280K | 0.01% | 420 |
|
|
2022
Q2 | $12K | Sell |
35
-10,566
| -100% | -$4.31M | ﹤0.01% | 407 |
|
|
2022
Q1 | $5.8M | Buy |
10,601
+3,171
| +43% | +$1.67M | 0.15% | 97 |
|
|
2021
Q4 | $4.89M | Sell |
7,430
-3,830
| -34% | -$2.4M | 0.13% | 131 |
|
|
2021
Q3 | $7M | Buy |
11,260
+9,105
| +423% | +$6.12M | 0.2% | 86 |
|
|
2021
Q2 | $1.46M | Sell |
2,155
-2,061
| -49% | -$1.14M | 0.04% | 208 |
|
|
2021
Q1 | $2.06M | Buy |
4,216
+3,308
| +364% | +$1.66M | 0.06% | 161 |
|
|
2020
Q4 | $454K | Buy |
908
+877
| +2,829% | +$392K | 0.02% | 269 |
|
|
2020
Q3 | $12K | Sell |
31
-155
| -83% | -$57.3K | ﹤0.01% | 380 |
|
|
2020
Q2 | $61K | Sell |
186
-2,232
| -92% | -$646K | ﹤0.01% | 364 |
|
|
2020
Q1 | $586K | Buy |
2,418
+2,101
| +663% | +$548K | 0.04% | 229 |
|
|
2019
Q4 | $83K | Sell |
317
-4,885
| -94% | -$1.29M | 0.01% | 429 |
|
|
2019
Q3 | $1.42M | Buy |
5,202
+5,007
| +2,568% | +$1.39M | 0.1% | 141 |
|
|
2019
Q2 | $54K | Buy |
+195
| New | +$48K | ﹤0.01% | 417 |
|
|
2019
Q1 | – | Sell |
-1,554
| Closed | -$289K | – | 300 |
|
|
2018
Q4 | $289K | Buy |
+1,554
| New | +$319K | 0.04% | 170 |
|
Other funds holding IDXX
VCM
VPM
Ossiam's IDXX Position: Q1 2026 in Review
Ossiam increased its Idexx Laboratories (IDXX) stake by 7.3% in Q1 2026, buying an estimated $322K and bringing the position to 7,337 shares worth $4.12M. The position accounts for 0.07% of the portfolio, ranked #120.
Ossiam first reported a position in IDXX in Q4 2018 and has held it in 29 quarters since. The position peaked at $7.02M in Q3 2025. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Ossiam held 7,337 shares of Idexx Laboratories worth $4.12M as of Q1 2026.
- Ossiam bought 502 Idexx Laboratories shares in Q1 2026, an estimated $322K.
- Idexx Laboratories made up 0.07% of Ossiam's portfolio in Q1 2026, its #120 holding.
- Ossiam first reported a position in Idexx Laboratories in Q4 2018 and has held it in 29 quarters since.
- Ossiam's Idexx Laboratories position peaked at $7.02M in Q3 2025.
- 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Ossiam's 13F filing for Q1 2026, filed 14 May 2026.